Literature DB >> 25636049

Does contralateral suppression at adrenal venous sampling predict outcome following unilateral adrenalectomy for primary aldosteronism? A retrospective study.

Martin J Wolley1, Richard D Gordon, Ashraf H Ahmed, Michael Stowasser.   

Abstract

CONTEXT: In primary aldosteronism (PA), adrenal vein sampling (AVS) distinguishes unilateral and bilateral disease by comparison of aldosterone/cortisol (A/F) ratios. There is controversy about the criteria for interpretation, however, and in particular it is not clear whether contralateral suppression (CS) (defined as A/F(adrenal) ≤ A/F(peripheral) on the unaffected side) is important. We therefore performed a retrospective study to determine whether CS in surgically treated unilateral PA was associated with blood pressure (BP) and biochemical outcomes. SETTING AND
DESIGN: Patients who underwent unilateral adrenalectomy for PA after successful AVS were included if the lateralization index (A/F(dominant):A/F(nondominant)) was ≥ 2. Cases were reviewed at 6 to 24 months follow-up for outcomes with respect to the presence and degree of CS.
RESULTS: Sixty-six of 80 patients had CS. Baseline characteristics were similar. At postoperative follow-up, those with CS had lower systolic BP (SBP) (128 mm Hg vs 144 mm Hg, P = .001), a greater proportion with cure or improvement of hypertension (96% vs 64%, P = .0034), a greater proportion with biochemical cure of PA on fludrocortisone suppression testing (43 of 49 [88%] vs 4 of 9 [44%], P = .002) and were taking a lower median number of antihypertensive medications (0 vs 1.5, P = .0032). In a multivariate model, the degree of CS and preoperative SBP were both significantly correlated with postoperative SBP, but the lateralization index, sex, and age were not.
CONCLUSION: In this study, the presence of CS correlated with good BP and biochemical outcomes from surgery. This finding suggests that CS should be a factor in deciding whether to offer surgery for treatment of PA.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25636049     DOI: 10.1210/jc.2014-3676

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  27 in total

1.  Lateralization index but not contralateral suppression at adrenal vein sampling predicts improvement in blood pressure after adrenalectomy for primary aldosteronism.

Authors:  M Tagawa; M Ghosn; H Wachtel; D Fraker; R R Townsend; S Trerotola; D L Cohen
Journal:  J Hum Hypertens       Date:  2017-01-12       Impact factor: 3.012

2.  11-Deoxycortisol may be superior to cortisol in confirming a successful adrenal vein catheterization without cosyntropin: a pilot study.

Authors:  Naris Nilubol; Steven J Soldin; Dhaval Patel; Muthoni Rwenji; Jianghong Gu; Likhona S Masika; Richard Chang; Constantine A Stratakis; Electron Kebebew
Journal:  Int J Endocr Oncol       Date:  2017-04-27

3.  A Multi-institutional Comparison of Adrenal Venous Sampling in Patients with Primary Aldosteronism: Caution Advised if Successful Bilateral Adrenal Vein Sampling is Not Achieved.

Authors:  Tracy S Wang; Greg Kline; Tina W Yen; Ziyan Yin; Ying Liu; William Rilling; Benny So; James W Findling; Douglas B Evans; Janice L Pasieka
Journal:  World J Surg       Date:  2018-02       Impact factor: 3.352

4.  Subtype prediction of primary aldosteronism by combining aldosterone concentrations in the left adrenal vein and inferior vena cava: a multicenter collaborative study on adrenal venous sampling.

Authors:  Yuichi Fujii; Hironobu Umakoshi; Norio Wada; Takamasa Ichijo; Kohei Kamemura; Yuichi Matsuda; Tatsuya Kai; Tomikazu Fukuoka; Ryuichi Sakamoto; Atsushi Ogo; Tomoko Suzuki; Kazutaka Nanba; Mika Tsuiki; Mitsuhide Naruse
Journal:  J Hum Hypertens       Date:  2017-11-24       Impact factor: 3.012

5.  Discordance between imaging and immunohistochemistry in unilateral primary aldosteronism.

Authors:  Aya T Nanba; Kazutaka Nanba; James B Byrd; James J Shields; Thomas J Giordano; Barbara S Miller; William E Rainey; Richard J Auchus; Adina F Turcu
Journal:  Clin Endocrinol (Oxf)       Date:  2017-09-04       Impact factor: 3.478

6.  Cosyntropin stimulation in adrenal vein sampling improves the judgment of successful adrenal vein catheterization and outcome prediction for primary aldosteronism.

Authors:  Midori Yatabe; Kanako Bokuda; Kaoru Yamashita; Satoshi Morimoto; Junichi Yatabe; Yasufumi Seki; Daisuke Watanabe; Satoru Morita; Shuji Sakai; Atsuhiro Ichihara
Journal:  Hypertens Res       Date:  2020-04-30       Impact factor: 3.872

7.  Treatment of primary aldosteronism is associated with a reduction in the severity of obstructive sleep apnoea.

Authors:  M J Wolley; E Pimenta; D Calhoun; R D Gordon; D Cowley; M Stowasser
Journal:  J Hum Hypertens       Date:  2017-04-06       Impact factor: 3.012

Review 8.  Immunohistochemistry of the Human Adrenal CYP11B2 in Normal Individuals and in Patients with Primary Aldosteronism.

Authors:  Celso E Gomez-Sanchez; Elise P Gomez-Sanchez; Koshiro Nishimoto
Journal:  Horm Metab Res       Date:  2020-04-14       Impact factor: 2.936

Review 9.  Diagnosing and Managing Primary Aldosteronism in Hypertensive Patients: a Case-Based Approach.

Authors:  Robert M Carey
Journal:  Curr Cardiol Rep       Date:  2016-10       Impact factor: 2.931

10.  Body mass index and contralateral ratio predict outcome following unilateral adrenalectomy in primary aldosteronism.

Authors:  Kanako Bokuda; Midori Yatabe; Yuki Mizuguchi; Michita Niiyama; Yasufumi Seki; Daisuke Watanabe; Junichi Yatabe; Takashi Ando; Satoshi Morimoto; Atsuhiro Ichihara
Journal:  Hypertens Res       Date:  2017-10-05       Impact factor: 3.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.